{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:11:49Z","timestamp":1778537509486,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd007633","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000}}],"reference-count":87,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007633.pub2","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T13:33:57Z","timestamp":1359466437000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Interventions for nail psoriasis"],"prefix":"10.1002","volume":"2013","author":[{"given":"Anna Christa Q","family":"de Vries","sequence":"first","affiliation":[{"name":"Academic Medical Center; Department of Dermatology; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie A","family":"Bogaards","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Dermatology; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotty","family":"Hooft","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Dutch Cochrane Centre; Room J1B - 108 - 2 P.O. Box 22700 Amsterdam Netherlands 1100 DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Velema","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Dermatology; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Pasch","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Centre; Department of Dermatology; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine; Department of Dermatology; 5 East 98th Street 5th Floor New York USA 10029"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis I","family":"Spuls","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Dermatology; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/09546639909056030","article-title":"Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation","volume":"10","author":"Baran","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/09546639909056030","article-title":"Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation","volume":"10","author":"Baran","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000068469","article-title":"Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study","volume":"206","author":"Cannavo","year":"2003","journal-title":"Dermatology"},{"issue":"Suppl s1","key":"10.1002\/14651858.CD007633.pub2-BIB0004|cit4","first-page":"P27","article-title":"Treatment of psoriatic nails with topical cyclosporin [Abstract]. 11th Congress of the European Academy of Dermatology and Venereology Prague October 2nd-6th, 2002","volume":"16","author":"Cannavo","year":"2002","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study","volume":"199","author":"Jong","year":"1999","journal-title":"Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0006|cit6","first-page":"129","article-title":"Treatment of psoriasic onychodystrophy with a hyaluronic acid product and chondroitinsulphates","volume":"129","author":"Flori","year":"1994","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"9","key":"10.1002\/14651858.CD007633.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","article-title":"Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study","volume":"25","author":"Gumusel","year":"2011","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1346-8138.2011.01347.x","article-title":"Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2\/3 clinical trial","volume":"39","author":"Igarashi","year":"2012","journal-title":"Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","article-title":"Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study","volume":"60","author":"Kavanaugh","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2340\/000155557590","article-title":"A therapeutic study of nail psoriasis using electron beams","volume":"75","author":"Kwang","year":"1995","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2340\/00015555756569","article-title":"Remission of ordinary psoriasis following a short clearance course of cyclosporin","volume":"75","author":"Levell","year":"1995","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0012|cit12","first-page":"80","article-title":"Psoriasis of the nails treated with grenz rays: a double-blind bilateral trial","volume":"69","author":"Lindelof","year":"1989","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9494","key":"10.1002\/14651858.CD007633.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000317775","article-title":"Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial. [Erratum appears in Dermatology 2011 Feb;222(1):4]","volume":"221","author":"Reich","year":"2010","journal-title":"Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007633.pub2-BIB0016|cit16","first-page":"1","article-title":"Infliximab produces a sustained and significant improvement in psoriasis over 50 weeks of continuous therapy. [Abstract O-10]. The 85th BAD Annual Meeting 5-8th July 2005, Glasgow, UK","volume":"153","author":"Reich","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year","volume":"58","author":"Rich","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD007633.pub2-BIB0018|cit18","first-page":"AB178","article-title":"Nail psoriasis improvement is maintained in patients with moderate to severe psoriasis treated with infliximab. [Abstract P2716]. American Academy of Dermatology 65th Annual Meeting 2nd-6th February 2007","volume":"56","author":"Rich","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007633.pub2-BIB0019|cit19","first-page":"171","article-title":"Significant response of nail psoriasis to infliximab in patients with moderate to severe psoriasis disease. [Abstract P06.43]. The 14th Congress of the European Academy of Dermatology and Venereology, 12-15th October 2005, London, UK","volume":"19","author":"Rich","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2340\/00015555-0195","article-title":"Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study","volume":"87","author":"Rigopoulos","year":"2007","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0021|cit21","first-page":"545","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: A double-blind, randomized, vehicle-controlled study. [Abstract 936]. The 62nd Annual Meeting of the Society for Investigative Dermatology","volume":"117","author":"Scher","year":"2001","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0022|cit22","unstructured":"Scher R Stiller M Zhu Y Tazarotene 0.1% gel in the treatment of nail psoriasis. [Abstract P0791] 20th World Congress of Dermatology; 1-5 July 2002, Paris 2002 1S523"},{"issue":"5","key":"10.1002\/14651858.CD007633.pub2-BIB0023|cit23","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0025|cit25","first-page":"279","article-title":"Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis","volume":"88","author":"Tzung","year":"2008","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2340\/0001555572134136","article-title":"A double-blind study of superficial radiotherapy in psoriatic nail dystrophy","volume":"72","author":"Yu","year":"1992","journal-title":"Acta Dermato-Venereologica"},{"issue":"1-2","key":"10.1002\/14651858.CD007633.pub2-BIB0027|cit27","first-page":"49","article-title":"Triamcinolone acetonide in ungual psoriasis","volume":"67","author":"Camacho Martinez","year":"1976","journal-title":"Actas Dermo-Sifiliograficas"},{"issue":"7","key":"10.1002\/14651858.CD007633.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1468-3083.2009.03209.x","article-title":"Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer","volume":"23","author":"Cantoresi","year":"2009","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1973.tb01921.x","article-title":"Allopurinol in psoriasis--a double-blind study","volume":"89","author":"Feuerman","year":"1973","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/030006059702500406","article-title":"Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study","volume":"25","author":"Lassus","year":"1997","journal-title":"The Journal of International Medical Research"},{"issue":"8","key":"10.1002\/14651858.CD007633.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","article-title":"Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis","volume":"23","author":"Luger","year":"2009","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007633.pub2-BIB0032|cit32","first-page":"25","article-title":"Low-dose ciclosporin A (Sandimmun) in psoriasis: A multicenter dose-finding study","volume":"66","author":"Mrowietz","year":"1991","journal-title":"H+G Zeitschrift fur Hautkrankheiten"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-008-0883-9","article-title":"Antigens from Leishmania amastigotes induced clinical remission of psoriasis","volume":"301","author":"O'Daly","year":"2009","journal-title":"Archives of Dermatological Research"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007633.pub2-BIB0034|cit34","first-page":"21","article-title":"Efficacy of topical calcipotriol in the treatment of nail psoriasis: A randomized double-blind placebo controlled trial. [Abstract 1020]. The 19th World Congress of Dermatology 15-20 June 1997, Sydney, Australia","volume":"38","author":"Abesamis-Cubillan","year":"1997","journal-title":"Australasian Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0035|cit35","first-page":"46","article-title":"Topical cyclosporin for nail psoriasis: a prospective, randomised placebo-controlled study. [Abstract]","volume":"20","author":"Baerveldt","year":"January 2010","journal-title":"Nederlands Tijdschrift voor Dermatologie en Venereologie"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007633.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"iii141","DOI":"10.1093\/rheumatology\/ker034","article-title":"High level responses in psoriatic arthritis patients treated with golimumab: Results from week 104 of the go-reveal study [Poster 254]. Rheumatology 2011 Brighton United Kingdom. Conference Start: 20110412 Conference End: 20110414","volume":"50","author":"Kavanaugh","year":"2011","journal-title":"Rheumatology"},{"issue":"S10","key":"10.1002\/14651858.CD007633.pub2-BIB0037|cit37","first-page":"664","article-title":"Methotrexate is not disease modifying in psoriatic arthritis: The MIPA trial. [Abstract] Conference: American College of Rheumatology\/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR\/ARHP 10 Philadelphia, PA United States. Conference Start: 20091016 Conference End: 20091021","volume":"60","author":"Kingsley","year":"2009","journal-title":"Arthritis & Rheumatism"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD007633.pub2-BIB0038|cit38","first-page":"AB7","article-title":"Improvement in nail psoriasis is associated with improved efficacy outcomes in hand and\/or foot psoriasis in adalimumab-treated patients: subanalysis of REACH. (Abstract P402) . Conference: 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204 Conference End: 20110208. Conference Publication","volume":"64","author":"Langley","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD007633.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/j.1365-2133.2011.10671.x","article-title":"A Phase 2 trial of LY2439821,an anti-interleukin-17 monoclonal antibody, given subcutaneously in patients with moderate to severe psoriasis [Abstract P-17]. Conference: 6th International Congress on Psoriasis: From Gene to Clinic London United Kingdom. Conference Start: 20111201 Conference End: 20111203","volume":"165","author":"Leonardi","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007633.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"i58","DOI":"10.1093\/rheumatology\/kep723","article-title":"Golimumab administered every four weeks as a subcutaneous injection in psoriatic arthritis: Nail, enthesitis, and dactylitis response in the randomized, placebo-controlled, go-reveal study [Abstract 97]. Conference: British Society for Rheumatology and British Health Professionals in Rheumatology Annual Meetings 2009, Rheumatology'09 Glasgow United Kingdom. Conference Start: 20090428 Conference End: 20090501","volume":"48","author":"McInnes","year":"2009","journal-title":"Rheumatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD007633.pub2-BIB0041|cit41","first-page":"AB139","article-title":"Adalimumab plus topical treatment (calcipotriol\/betamethasone) in the treatment of moderate to severe psoriasis: Effects on skin, scalp, and nails: Results from BELIEVE (Poster P3365) 68th Annual Meeting of the American Academy of Dermatology, AAD Miami, FL United States","volume":"62","author":"Thaci","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD007633.pub2-BIB0042|cit42","first-page":"AB135","article-title":"Effects of adalimumab monotherapy versus adalimumab plus betametha-sone\/calcipotriol on patient-reported outcomes in patients with palmo-plantar, nail, or scalp psoriasis (Poster P3350) 68th Annual Meeting of American Academy of Dermatology, AAD Miami, FL United States","volume":"62","author":"Thaci","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0043|cit43","unstructured":"EUCTR2004-004825-87-HU Efficacy and safety of 0,1%, 0,5% and 1% tazarotene nail lacquer formulation versus vehicle in nail psoriasis. International, multicenter, double-blind, randomized study of four parallel groups. - Dose ranging for Tazarotene nail lacquer www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2004-004825-87-HU"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0044|cit44","unstructured":"EUCTR2006-004453-18-FR A Randomised, Open-Label Preliminary Study To Assess The Effects Of Etanercept 50 mg Once Weekly For 24 Weeks And Etanercept 50 mg Twice Weekly For 12 weeks Reducing To Etanercept 50 mg Once Weekly For 12 weeks On Nail And Skin Symptoms In Patients With Nail Psoriasis And Plaque Psoriasis www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2006-004453-18-FR"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0045|cit45","unstructured":"EUCTR2006-006569-18-FR Efficacy and safety of 8% clobetasol nail lacquer formulation versus vehicle in nail psoriasis www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2006-006569-18-FR"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0046|cit46","unstructured":"EUCTR2010-019706-16-IT A randomized, double blind, placebo controlled, parallel groups, pilot study to assess the effects of two new nail lacquers, cyclosporine 5% and calcipotriol 0.005%, in the treatment of nail psoriasis - ND www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2010-019706-16-IT"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0047|cit47","unstructured":"NCT00581100 Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis www.clinicaltrials.gov\/show\/NCT00581100"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0048|cit48","unstructured":"NCT00666354 Dose response and safety study of topical methotrexate for the treatment of fingernail psoriasis www.clinicaltrials.gov\/show\/NCT00666354"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0049|cit49","unstructured":"NCT00999687 Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails www.clinicaltrials.gov\/show\/NCT00999687"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0050|cit50","unstructured":"NCT01107457 A Study in Patients With Moderate to Severe Psoriasis www.clinicaltrials.gov\/show\/NCT01107457"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.2006.02305.x","article-title":"Interobserver reliability of the Nail Psoriasis Severity Index","volume":"32","author":"Aktan","year":"2007","journal-title":"Clinical & Experimental Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2133.2003.05725.x","article-title":"A Nail Psoriasis Severity Index","volume":"150","author":"Baran","year":"2004","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0053|cit53","volume-title":"Dermatology","author":"Bolognia","year":"2003"},{"issue":"7","key":"10.1002\/14651858.CD007633.pub2-BIB0054|cit54","first-page":"1452","article-title":"Therapies for psoriatic nail disease. A systematic review","volume":"33","author":"Cassell","year":"2006","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0055|cit55","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0056|cit56","first-page":"2497","article-title":"Disorders of nails","volume-title":"Textbook of Dermatology","author":"Dawber","year":"1992"},{"issue":"5","key":"10.1002\/14651858.CD007633.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2230.2000.00663.x","article-title":"Management of nail psoriasis","volume":"25","author":"Berker","year":"2000","journal-title":"Clinical & Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sder.2008.12.003","article-title":"Management of psoriatic nail disease","volume":"28","author":"Berker","year":"2009","journal-title":"Seminars in Cutaneous Medicine & Surgery"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"Jong","year":"1996","journal-title":"Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1087-0024.2003.09110.x","article-title":"Quality of life in patients with psoriasis: a systematic literature review","volume":"9","author":"Korte","year":"2004","journal-title":"Journal of Investigative Dermatology Symposium Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0061|cit61","first-page":"174","article-title":"Nail psoriasis","volume":"50","author":"Farber","year":"1992","journal-title":"Cutis"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/120347540400800208","article-title":"Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol","volume":"8","author":"Feliciani","year":"2004","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"6","key":"10.1002\/14651858.CD007633.pub2-BIB0063|cit63","first-page":"565","article-title":"Nail psoriasis therapy. Review of the literature","volume":"134","author":"Forleo","year":"1999","journal-title":"Giornale Italiano di Dermatologia e Venerologia"},{"issue":"3","key":"10.1002\/14651858.CD007633.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/17469872.3.3.339","article-title":"Treatment options for nail psoriasis","volume":"3","author":"Gregoriou","year":"2008","journal-title":"Expert Review of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.jid.5700118","article-title":"Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients","volume":"126","author":"Gudjonsson","year":"2006","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0066|cit66","unstructured":"Higgins JPT Green S (editors) Cochrane handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011] Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD007633.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/rheumatology\/33.9.834","article-title":"Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease","volume":"33","author":"Jones","year":"1994","journal-title":"British Journal of Rheumatology"},{"issue":"7303","key":"10.1002\/14651858.CD007633.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD007633.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-4362.2001.01261-4.x","article-title":"Nail changes in psoriasis: a study of 167 patients","volume":"40","author":"Kaur","year":"2001","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Quality of Life Research"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7750.2008.08012","article-title":"Nail psoriasis and biologics","volume":"13","author":"Noiles","year":"2009","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaad.2004.11.044","article-title":"Modification of the Nail Psoriasis Severity Index","volume":"53","author":"Parrish","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9494","key":"10.1002\/14651858.CD007633.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007633.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1468-3083.2009.03364.x","article-title":"Approach to managing patients with nail psoriasis","volume":"23","author":"Reich","year":"2009","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000317775","article-title":"Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial.[Erratum appears in Dermatology. 2011 Feb;222(1):4]","volume":"221","author":"Reich","year":"2010","journal-title":"Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007633.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD007633.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008947","article-title":"Ustekinumab for plaque psoriasis","author":"Roberts","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10067-006-0307-1","article-title":"Rheumatic manifestations of psoriasis","volume":"26","author":"Sadek","year":"2007","journal-title":"Clinical Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10227-002-0143-0","article-title":"Psoriatic nails: a prospective clinical study","volume":"7","author":"Salomon","year":"2003","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000092283","article-title":"Epidemiology of psoriasis. Review and the German perspective","volume":"212","author":"Schafer","year":"2006","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD007633.pub2-BIB0082|cit82","first-page":"131","article-title":"The nails","volume-title":"Psoriasis","author":"Scher","year":"1990"},{"issue":"8","key":"10.1002\/14651858.CD007633.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007633.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0085|cit85","first-page":"482","article-title":"Clinical observations on nail changes in psoriasis","volume":"17","author":"Tham","year":"1988","journal-title":"Annals of the Academy of Medicine, Singapore"},{"issue":"4","key":"10.1002\/14651858.CD007633.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000018026","article-title":"Scalp psoriasis, clinical presentations and therapeutic management","volume":"197","author":"Kerkhof","year":"1998","journal-title":"Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD007633.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","article-title":"Extended report: nail disease in psoriatic arthritis -- clinically important, potentially treatable and often overlooked","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007633.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:17:33Z","timestamp":1733159853000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007633.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007633.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}